RRoche Read More China’s Simcere Zaiming signs $1.5 B deal with Roche for SIM0660 global development2026-09-02 China’s Simcere Zaiming signs $1.5 B deal with Roche for SIM0660 global development September 2, 2026 | Wednesday…
RRoche Read More China’s Simcere Zaiming signs $1.5 B deal with Roche for SIM0660 global development2026-09-02 China’s Simcere Zaiming signs $1.5 B deal with Roche for SIM0660 global development September 2, 2026 | Wednesday…
RRoche Read More Simcere Pharmaceutical Partners with Roche in Trispecific Antibody Licensing Deal Worth Up to $1.53 Billion — BigGo Finance2026-09-02 Chinese innovative drugmaker Simcere Pharmaceutical (2096.HK) has entered into a global exclusive licensing collaboration with Swiss pharmaceutical giant…
RRoche Read More Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development2026-09-01 NANJING, China, Sept. 1, 2026 /PRNewswire/ — Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced…